Crestline Management’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-62,969
Closed -$1.56M 76
2024
Q4
$1.56M Buy
62,969
+45,554
+262% +$1.13M 0.05% 327
2024
Q3
$427K Buy
+17,415
New +$427K 0.02% 393